rc 3095 has been researched along with Adjuvant Arthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brenol, CV; Brenol, JC; Dal-Pizzol, F; Edelweiss, MI; Oliveira, PG; Petronilho, F; Roesler, R; Schwartsmann, G; Xavier, RM | 1 |
| Brenol, JC; Cunha, FQ; Grespan, R; Meurer, L; Oliveira, PG; Pinto, LG; Roesler, R; Schwartsmann, G; Xavier, RM | 1 |
2 other study(ies) available for rc 3095 and Adjuvant Arthritis
| Article | Year |
|---|---|
Effects of an antagonist of the bombesin/gastrin-releasing peptide receptor on complete Freund's adjuvant-induced arthritis in rats.
Topics: Animals; Arthritis, Experimental; Bombesin; Freund's Adjuvant; Interferon-gamma; Interleukin-10; Interleukin-1beta; Interleukin-6; Male; Peptide Fragments; Placebos; Random Allocation; Rats; Rats, Wistar; Receptors, Bombesin; Tarsus, Animal; Tumor Necrosis Factor-alpha | 2008 |
Protective effect of RC-3095, an antagonist of the gastrin-releasing peptide receptor, in experimental arthritis.
Topics: Animals; Arthritis, Experimental; Bombesin; Cartilage, Articular; Cell Movement; Cell Proliferation; Joints; Male; Mice; Neutrophils; Peptide Fragments; Receptors, Bombesin; Synovial Membrane; Treatment Outcome | 2011 |